Get the Stockscreener App
2.16
0.46%
-0.010
Akebia Therapeutics Inc Stock (AKBA) Latest News
Akebia Therapeutics' chief accounting officer sells $63,424 in stock - MSN
Steven Keith Burke Sells 50,506 Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) Stock - MarketBeat
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Insider Sells $116,804.10 in Stock - MarketBeat
Insider Selling: Akebia Therapeutics, Inc. (NASDAQ:AKBA) CEO Sells 144,250 Shares of Stock - MarketBeat
Akebia Therapeutics' chief commercial officer sells $116,804 in stock - MSN
Akebia therapeutics' chief medical officer sells $106,062 in stock - Investing.com
Akebia therapeutics' chief medical officer sells $106,062 in stock By Investing.com - Investing.com Canada
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Akebia's Latest Talent Investment: Strategic Options Grant Details Revealed - StockTitan
Akebia Therapeutics' chief accounting officer sells $63,424 in stock By Investing.com - Investing.com Canada
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Sees Significant Increase in Short Interest - MarketBeat
Akebia Therapeutics CEO John Butler sells $302,925 in stock - MSN
SEC Form S-8 filed by Akebia Therapeutics Inc. - Quantisnow
Akebia Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
Akebia Therapeutics (NASDAQ:AKBA) Trading 10.9% HigherTime to Buy? - MarketBeat
H.C. Wainwright maintains Akebia stock Buy rating, $7.50 target - MSN
Akebia Therapeutics (NASDAQ:AKBA) Trading Down 4.4%What's Next? - MarketBeat
Akebia Therapeutics (NASDAQ:AKBA) Earns "Buy" Rating from HC Wainwright - MarketBeat
Improved Revenues Required Before Akebia Therapeutics, Inc. (NASDAQ:AKBA) Stock's 30% Jump Looks Justified - Simply Wall St
Akebia Therapeutics (NASDAQ:AKBA) Trading Up 10.9%Here's What Happened - MarketBeat
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Shares Bought by Barclays PLC - MarketBeat
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Shares Acquired by Barclays PLC - Defense World
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listi - GuruFocus.com
What is HC Wainwright's Forecast for AKBA FY2024 Earnings? - MarketBeat
Equities Analysts Issue Forecasts for AKBA FY2024 Earnings - Defense World
FY2024 Earnings Forecast for AKBA Issued By HC Wainwright - MarketBeat
Analysts Offer Predictions for AKBA FY2029 Earnings - MarketBeat
Brokers Issue Forecasts for AKBA FY2029 Earnings - MarketBeat
Akebia Therapeutics (NASDAQ:AKBA) Earns Buy Rating from HC Wainwright - Defense World
Akebia Therapeutics (NASDAQ:AKBA) Rating Lowered to Sell at StockNews.com - MarketBeat
H.C. Wainwright optimistic on Akebia shares despite risks to commercial opportunity - Investing.com Nigeria
HC Wainwright Reiterates "Buy" Rating for Akebia Therapeutics (NASDAQ:AKBA) - MarketBeat
Akebia announces ‘multiple positive business updates’ - Yahoo Finance
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Shares Sold by Jane Street Group LLC - Defense World
Vafseo tablets start U.S. shipment, Akebia plans Phase 3 trial - Investing.com India
Akebia Therapeutics Announces Multiple Positive Business Updates - citybiz
Akebia's Vafseo Launch Secures Coverage for Nearly All U.S. Dialysis Patients, 99% of Doctors Show Interest - StockTitan
Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Kilgore News Herald
Akebia Therapeutics (NASDAQ:AKBA) Upgraded at StockNews.com - MarketBeat
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Stock Holdings Lifted by Barclays PLC - Defense World
Geode Capital Management LLC Has $6.28 Million Position in Akebia Therapeutics, Inc. (NASDAQ:AKBA) - Defense World
New Strong Sell Stocks for January 3rd - Yahoo Finance
Akebia Therapeutics Awards Inducement Stock Options to New Employee at $1.90 Per Share - StockTitan
Short Interest in Akebia Therapeutics, Inc. (NASDAQ:AKBA) Expands By 21.7% - Defense World
Akebia Therapeutics (NASDAQ:AKBA) Stock Rating Lowered by StockNews.com - MarketBeat
State Street Corp Purchases 683,287 Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) - MarketBeat
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Shares Purchased by State Street Corp - Defense World
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Short Interest Update - MarketBeat
Akebia Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GuruFocus.com
XTX Topco Ltd Makes New $58,000 Investment in Akebia Therapeutics, Inc. (NASDAQ:AKBA) - Defense World
Wellington Management Group LLP Takes $534,000 Position in Akebia Therapeutics, Inc. (NASDAQ:AKBA) - MarketBeat
High Growth Tech Stocks To Watch In December 2024 - Simply Wall St
0.25%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):